<?xml-stylesheet type="text/xsl" href="https://community.appian.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Enterprise Risk Assessment and Migration Solution (ERAMS)</title><link>/b/appmarket/posts/enterprise-risk-assessment-and-migration-solution-erams</link><description>Overview 
 In the realm of pharmaceuticals, a variety of risks can emerge throughout the stages of drug development, exerting influence on the triumph of drug creation and clinical trials. These risks have the potential to give rise to substantial operational</description><dc:language>en-US</dc:language><generator>Telligent Community 12</generator></channel></rss>